Formulation Strategies and In Vitro Characterization of Talquetamab-Loaded Nanocarriers for Targeted Immunotherapy in Multiple Myeloma. IJRDT [Internet]. 2026 Mar. 18 [cited 2026 Sep. 10];4(1):41-6. Available from: https://ijrdt.com/index.php/files/article/view/166